title: Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.
abstract: Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal burden. The present guidelines summarise current literature, generating expert consensus recommendations for the treatment of ADHD in children and adults. These guidelines also provide a review of recent research in the fields of neuroimaging, neuropsychology and genetics of ADHD. Novel discoveries in these areas have informed physiological models for the disease. Since the publication of the previous British Association for Psychopharmacology guidelines in 2008, new drugs have been licensed and further compounds are being investigated. The publication of randomised controlled trials of psychological interventions has contributed to the range of treatment options for ADHD. As the disorder has been diagnosed more frequently there has been greater focus on comorbid conditions and how they impact treatment. Services have continued to develop for the treatment of ADHD in adults and care agreements have been introduced to facilitate access to treatment.
authors: 1University of Bristol, Bristol, UK.
authors: Blanca
authors: B
authors: Bolea-Alamañac
authors: David J
authors: DJ
authors: Nutt
authors: Marios
authors: M
authors: Adamou
authors: Phillip
authors: P
authors: Asherson
authors: Stephen
authors: S
authors: Bazire
authors: David
authors: D
authors: Coghill
authors: David
authors: D
authors: Heal
authors: Ulrich
authors: U
authors: Müller
authors: John
authors: J
authors: Nash
authors: Paramala
authors: P
authors: Santosh
authors: Kapil
authors: K
authors: Sayal
authors: Edmund
authors: E
authors: Sonuga-Barke
authors: Susan J
authors: SJ
authors: Young
mesh_terms: D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D032921:Consensus; D019317:Evidence-Based Medicine; D006801:Humans
chemical_list: D000697:Central Nervous System Stimulants
keywords: ADD; ADHD; BAP; attention deficit and hyperactivity disorder; hyperkinetic disorder